We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Skinbiotherapeutics Plc | SBTX | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
16.25 | 16.25 | 16.25 | 16.25 |
Industry Sector |
---|
PHARMACEUTICALS & BIOTECHNOLOGY |
Top Posts |
---|
Posted at 19/11/2024 09:51 by kreature Because then investors can speculate as to whatever may or may not be happening, and potentially misunderstand and make bad investment decisions.Should have been an RNS Reach at best. Lacking any useful detail imo |
Posted at 19/11/2024 08:33 by 1maxreward As for the RNS, seems to be great news for investors as they don't need to raise anymore funds. Hopefully revenue details will follow shortly and FY2025 will be an interesting year for SBTX. Can't wait! |
Posted at 04/11/2024 21:27 by kreature 200k was well worth it for entertainment purposes imv. Plus good publicity if any new investors want to consider getting shafted ? |
Posted at 29/10/2024 13:01 by kreature Well it’s only fair, private investors should invest over their cash to those few who really deserve it . Imo |
Posted at 23/10/2024 18:25 by kreature ‘ No rationale for share price movement ‘For balance, I’d say the rational could be…. 1. Profit taking following a 50% share price rise 2. Uncertainty concerning the Opti situation 3. Investors understanding that turnover is not net profit 4. Just a general sense of binaryness in the air. In my opinion, as always. |
Posted at 17/10/2024 08:55 by putinaire The thing is, as the trio of opti/sbtx/pbx come as a package sold to investors - there is never any escape allowed in the churning process |
Posted at 17/10/2024 08:44 by putinaire A bit strange looking back on the threads over the years, nobody ever asked to see the pics of manufacturing and distribution centres. It seems investors are happy with the images in other peoples mindsIt would be great promo though, to show them all |
Posted at 16/10/2024 16:06 by kreature yes, all investors should win so long as they are loyal PIs who like Liverpool and live in Manchester and speak Chinese? |
Posted at 15/10/2024 09:44 by cowickhaller All playing out exactly as I thought.Great that SBTX now have a ‘Croda insider’ on board, that will level things up somewhat. There were things in the podcast that have not really been picked up on. A few examples. SBTX & Croda are planning further collaborations. This ties SBTX in further with Croda and together they could be a real powerhouse in their chosen field. SA talked about Matrixyl and replacing it. SA has to be careful with what he says, understandably so, but listen to the mood music and watch the body language. Finally SA talks about not resting till the SBTX share price is over £1. I fully endorse his conservatism. If this takes off as expected, we are certainly talking multiples of that. With the CRDA share price bouncing around the lows, CRDA need this development to succeed and it will. It’s not often industrial chemical companies like CRDA make the news, unless it’s for the wrong reasons. I predict it will happen here for the right reasons, April 2025. A blink of an eye for seasoned investors but a lifetime for some. |
Posted at 22/9/2024 11:33 by putinaire OPTI has failed everyone for 10 years.The RNS business model here is template. Already proven so in the selfie study rise and fall. Obviously there are no real investors here. Just RNS spike playyers needing green investors |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions